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Edited by Christian GriesingerAbstract High-level overexpression of G protein-coupled recep-
tors GPCRs in mammalian cells remains a diﬃcult task inspite
of newly developed virus based expression systems. Here, we
show that the functional expression level of the recombinant
bradykinin receptor (B2R) in mammalian cells can be increased
up to sixfold just by the addition of dimethylsulphoxide in the
culture medium. Total expression level, cellular localization
and binding aﬃnity of the recombinant receptor for its endoge-
nous ligand remains unaltered. The strategy presented here, with
recombinant B2R as a case example, is applicable to other
GPCRs and provides a generic tool to improve the functional
expression level of recombinant GPCRs in mammalian cells.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Localization1. Introduction
G protein-coupled receptors (GPCRs) are integral mem-
brane proteins with seven transmembrane helices and they play
regulatory roles in many diﬀerent cellular and physiological
processes [1]. Approximately half of the currently available
drugs target these receptors [2,3]. However, only little struc-
tural information is available on GPCRs and therefore, struc-
ture based drug design has not been possible. In recent years, a
number of heterologous expression systems have been used for
overexpression of recombinant GPCRs [4]. Out of these, mam-
malian cells represent the most suitable hosts for heterologous
expression of human recombinant GPCRs as they provide nat-
ural like membrane environment. However, transient transfec-
tion results in low expression levels of recombinant GPCRs.
To overcome this problem, the Semliki Forest virus based vec-
tors have been developed to overexpress recombinant GPCRs
in mammalian cells [5]. Although some GPCRs have been ex-
pressed at high levels using the SFV system, for others, the
expression level remain either low or moderate [5,6]. Therefore,
further attempts are required to improve the functional expres-Abbreviations: GPCR, G protein-coupled receptor; DMSO, di-
methylsulphoxide; BHK cells, baby hamster kidney cells
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cently, a positive eﬀect of dimethylsulphoxide on the
expression level of recombinant GPCRs in Pichia pastoris
was reported [7] and that led us to investigate if it is applicable
to mammalian cells also.
Here, we report that dimethylsulphoxide (DMSO) exerts a
similar positive eﬀect in mammalian cells also and present a
strategy to improve the functional expression level of low or
moderately expressed GPCRs in mammalian cells. As a case
example, we evaluated the eﬀect of DMSO on the functional
expression of the recombinant B2R in baby hamster kidney
cells (BHK cells). We also studied the eﬀect of DMSO on total
expression, binding aﬃnity and localization of the recombi-
nant receptor. In addition, eﬀect of DMSO on the physical
parameters of the host cells was also evaluated.2. Materials and methods
2.1. Materials
[3H]Bradykinin (60–90 Ci/mmol) was purchased from NEN Life Sci-
ence Products (Boston, MA, USA) and DMSO was obtained from Sig-
ma (St. Louis, MO, USA). The cell culture medium, glutamine,
phosphate buﬀer saline (PBS), trypsin–EDTA, and penicillin–strepto-
mycin solution were obtained from Cell Concepts GmbH (Umkirch,
Germany) or Sigma (St. Louis, MO, USA). Fetal calf serum was from
PAA laboratories (Colbe, Germany). a-Chymotrypsin was from ICN
chemicals (CA, USA) and aprotinin from Roche Applied Science
(Mannheim, Germany). Electroporation cuvettes were obtained from
Bio-Rad laboratories (CA, USA). SP6 polymerase, transcription buﬀer
and restriction enzymes were from MBI fermentas (St. Leon-Rot, Ger-
many). Immobilon-P polyvinylidene diﬂuoride (PVDF) membranes
were fromMillipore (Bedford, MA, USA). Anti-his antibody and alka-
line phosphatase-coupled secondary antibody were obtained from
Sigma (St. Louis, MO, USA).
2.2. Cell culture and expression of recombinant receptor
Monolayer culture of baby hamster kidney cells (BHK-21) were
grown in Dulbecco’s modiﬁed Eagle’s medium supplemented with
10% foetal calf serum (FCS), 2 mM glutamine and 0.1% streptomy-
cin–penicillin. BHK cells in suspension were cultured using Glasgow
minimal essential medium supplemented with 5% FCS, 2 mM gluta-
mine, 10 mM tryptose phosphate broth and 0.1% streptomycin–peni-
cillin. Cells were maintained in a humiﬁed atmosphere at 37 C with
5% CO2. Generation of virus stocks and infection of cells have been
described previously [8]. Diﬀerent concentrations (v/v) of DMSO were
added to the cells at the time of infection.
2.3. Membrane preparation and [3H]bradykinin binding assay
Membrane preparation and radioligand binding assay was per-
formed as published earlier [8]. In brief, the cells were harvested 24 h
post-infection, resuspended in cold breaking buﬀer (50 mM Tris/HCl,
pH 7.4, 100 mM NaCl, 10 mM EDTA, and complete protease inhibi-
tor cocktail) and lysed by nitrogen cavitation (500–800 psi) (Parrblished by Elsevier B.V. All rights reserved.
Fig. 1. Eﬀect of DMSO on functional expression of recombinant B2R.
[3H]Bradykinin binding analysis on membranes prepared from BHK
cells expressing B2R (with or without DMSO). The values represent an
average of three independent experiments.
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(3000 · g, 10 min, 4 C) to remove the nuclei and cell debris and the
membranes were pelleted by ultracentrifugation (100000 · g, 1 h,
4 C).
[3H]Bradykinin binding assay was performed on membranes (5 lg of
total protein per assay point) using binding buﬀer (50 mM Tris/HCl,
pH 7.4, 100 mM NaCl, 5 mM EDTA and complete protease inhibitor
cocktail) at 4 C for 40–45 min. 10 nM [3H]bradykinin was used for
single point measurements and 0.1–25 nM [3H]bradykinin was used
for saturation binding analysis. Following incubation, the reaction
was terminated by rapid ﬁltration through GF/C glass–ﬁber ﬁlters,
presoaked in 0.3% (v/v) polyethyleneimine. Filters were washed four
times with ice cold binding buﬀer and radioactivity was measured by
liquid scintillation counting.
2.4. Immunoblot analysis and confocal microscopy
Western blot and confocal imaging was essentially carried out as de-
scribed earlier [8]. Brieﬂy, proteins were separated using 10–12% SDS–
PAGE and then electrophoretically transferred to a PVDF membrane.
The PVDF membranes were incubated in 5% (w/v) non-fat dried milk
powder in TBST buﬀer (25 mM Tris, 192 mM glycine, 20% methanol,
and 0.1% Tween-20) for 1 h at room temperature. Subsequently, the
proteins were visualized using the anti-his antibody and the alkaline
phosphate-conjugated secondary antibody according to the manufac-
turer’s protocol (Sigma).
For localization analysis, the BHK cells expressing the B2R–eGFP
fusion protein were ﬁxed with 4% (v/v) paraformaldehyde for 15 min
at room temperature. Subsequently, the cells were washed three times
with PBS, three times with water and then mounted onto glass slides
using the gel mount medium (Sigma). Cells were analyzed using a Lei-
ca confocal laser-scanning microscope (488 nm for eGFP and 550 nm
for Cy3).
2.5. Analysis of physical parameters of DMSO treated cells
BHK cells were incubated with diﬀerent concentrations of DMSO
and after 24 h, analyzed by CEDEX Automated Cell Culture Analyzer
(Innovatis AG, Bielefeld, Germany) for cell number, cell viability, cell
compactness, cell diameter and cell aggregation rate.Fig. 2. Saturation binding analysis of recombinant B2R. [
3H]Brady-
kinin binding was measured on membranes from BHK cells expressing
B2R with (2%) or without DMSO. The dissociation constant (Kd) and
maximum expression level (Bmax) were calculated with the Kaleida-
Graph software by non-linear regression using a single site model.3. Results and discussion
3.1. Eﬀect of DMSO on functional expression and binding
aﬃnity of the recombinant B2R
We have recently reported expression and characterization
of the human B2R in BHK cells using the Semliki Forest virus
vectors [8]. An expression level of 10 ± 1 pmol/mg was ob-
served, which is only moderate from the point of view of
large-scale production. In an attempt to increase it further,
we evaluated the eﬀect of DMSO on the expression level of
B2R in BHK cells. The cells were infected with recombinant
B2R construct and diﬀerent amounts of DMSO were added
in the culture medium. 24 h post-infection, membranes were
prepared and [3H]bradykinin binding was measured. As shown
in Fig. 1, a signiﬁcant increase in [3H]bradykinin binding was
observed upon addition of DMSO. Best expression level was
obtained in the presence of 2% DMSO and further increase
of DMSO concentration had adverse eﬀects on B2R expression
level.
The expression level of B2R in presence of 2% DMSO corre-
sponds to 55 ± 5 pmol/mg (0.5 mg recombinant receptor per li-
tre culture). This expression level of B2R is maximum
compared to any other expression system for this particular
receptor and it is one of the best expression levels of GPCRs
obtained using the Semliki Forest virus system [5].
In order to check if the addition of DMSO alters the aﬃnity
of the recombinant receptor for its cognate ligand, a saturation
binding experiment was performed. Membranes prepared fromBHK cells grown in absence or presence of 2% DMSO was
used. As shown in Fig. 2, a Kd value of 0.15 nM was observed
in the membranes prepared from DMSO treated cells, which is
similar to that obtained in the membranes of untreated BHK
cells (0.12 nM). Taken together, these results suggest that addi-
tion of DMSO improves functional expression of B2R without
having any adverse eﬀect on the binding aﬃnity of the recep-
tor.
3.2. Total expression and localization analysis of the
recombinant receptor
Next, we determined if addition of DMSO aﬀects the total
expression of recombinant B2R as determined by Western blot
analysis. Membranes were prepared from BHK cells express-
ing B2R in absence or presence (1–2%) of DMSO and probed
using anti-his antibody. As revealed in Fig. 3, no signiﬁcant
change was observed in the intensity of recombinant B2R band
on the Western blot, indicating that the total expression of re-
combinant receptor remains unchanged upon DMSO treat-
ment.
We have previously reported that recombinant B2R exhibits
intracellular localization in BHK cells [8]. It is believed that
Fig. 3. Western blot analysis of the recombinant B2R using anti-his
antibody. Lane 1–3, 10 lg of membranes from BHK cells expressing
B2R in presence of diﬀerent concentrations of DMSO (lane 1–3 = 0–
2%).
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ing machinery of the host cells leading to intracellular reten-
tion of the receptors. Colocalization of recombinant B2R
with calnexin (an ER marker) indicated that the recombinant
receptor is mainly retained in the endoplasmic reticulum
(Fig. 4A–C). In order to investigate if DMSO induced increase
in functional expression results from altered traﬃcking of the
recombinant B2R, we used DMSO treated BHK cells (express-
ing B2R–eGFP construct) for confocal microscopy. As shown
in Fig. 4D–F, even in DMSO treated cells, the recombinant
receptor was colocalized with calnexin, suggesting expression
of B2R in the endoplasmic reticulum, as in DMSO untreated
cells (A–C).Fig. 4. Localization analysis of the recombinant B2R. BHK cells were infect
scanning microscope (488 nm for eGFP and 550 nm for Cy3).These data suggest that increase in functional expression of
B2R upon DMSO treatment is not a result of increased protein
synthesis or surface translocation of the recombinant receptor.
Rather, it is more likely that DMSO aﬀects the folding of the
recombinant B2R, resulting in an increased population of
those receptors which can bind to its ligand. However, this
possibility remains to be explored further.3.3. Eﬀect of DMSO on the physical parameters of BHK cells
Previous studies suggest that DMSO can induce morpholog-
ical changes in mouse erythroleukemic cells [10] and it can also
induce diﬀerentiation in neuroblastoma cells [11]. In contrast,
it is also reported that DMSO can block diﬀerentiation of
myoblasts, adipocytes and antibody producing plasma cells
[12–15]. To address the eﬀect of DMSO on physical parame-
ters of BHK cells, if any, we compared the cell number, viabil-
ity, compactness, aggregation and diameter of DMSO treated
and untreated cells. As shown in Fig. 5A, the total cell number
in DMSO treated samples was slightly decreased suggesting an
inhibitory eﬀect of DMSO on cell division. More importantly,
the cell viability was reduced slightly up to 2% of DMSO, but
further increase of DMSO resulted in severe cell death
(Fig. 5B). This might explain the decrease in functional expres-
sion level of B2R in presence of 3% DMSO (as observed in
Fig. 1). Another striking alteration in response to DMSO addi-
tion was the cell aggregation behaviour. DMSO treated cells
showed up to ﬁvefold less aggregation rate compared to the
untreated cells (Fig. 5C). The cell compactness was not much
changed but a slight increase in the cell diameter was observed
in DMSO treated cells (Fig. 5D–E).
We next analyzed the morphological changes in the BHK
cells (adherent cultures) using diﬀerential interference contrast
microscopy. It was observed that in presence of DMSO (up to
2%), the BHK cells were slightly elongated (Fig. 6A–C). Fur-
ther increase in DMSO concentration resulted in rounded cells
indicating cell death (data not shown).ed with B2R–eGFP fusion construct and visualized by confocal laser-
Fig. 5. Evaluation of the eﬀect of DMSO on physical parameters of BHK cells. Cells were grown in presence or absence of DMSO and subsequently
analysed by CEDEX automated cell culture analyzer. Values represent an average of three independent experiments.
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recombinant GPCRs
Next, we asked if the positive eﬀect of DMSO is applicable
to other GPCRs expressed in BHK cells. We found that the
functional expression of recombinant human angiotensin II
type 1 receptor and the human neuromedin subtype 2 receptor
were also improved four to sixfold by addition of DMSO (Shu-
kla et al., manuscript in preparation). This result indicates thatFig. 6. Morphological changes in BHK cells upon addition of DMSO. Cells
C = 2%) and subsequently analysed by diﬀerential image contrast microscopuse of DMSO might be a general strategy to increase the func-
tional expression level of recombinant GPCRs in mammalian
cells.
In S. cerevisiae, DMSO increases phospholipid biosynthesis
via up regulation of corresponding genes and also leads to cell
proliferation [16]. Additionally, DMSO also leads to decrease
in cell number and viability when used at high concentrations
[16]. In contrast, it has also been reported that DMSO inhibitswere treated with diﬀerent concentrations of DMSO (A = 0%, B = 1%,
y.
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genes involved in amino acid biosynthesis in S. cerevisiae
[17]. Until now, no systematic study has been done to investi-
gate the eﬀect of DMSO on membrane composition in mam-
malian cells. The exact mechanism of DMSO induced
increase in functional expression of GPCRs also remains to
be studied in detail.
In conclusion, we present a general approach to improve
functional expression of recombinant GPCRs in mammalian
cells. This strategy can be tested for other GPCRs not only
in the overexpression systems, but probably also in transient
transfection studies.
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